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The aim of this study was to evaluate the efficiency of oral treatment with sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) on reducing mercury
deposits in rat kidney after chronic exposure to inorganic mercury. The effect on kidney copper levels was also evaluated. The results showed that
after two months of exposure to 50 ppm of mercury (as mercuric chloride) the concentration of mercury in the kidney was 124 pg/g wet tissue. At
the same time copper concentration rose from 11 to 77 pg/g. DMPS treatment caused 2- and almost 4-fold reduction of mercury and copper,
respectively. This study demonstrates that chronic exposure to inorganic mercury may alter metabolism of copper and that DMPS is an effective
means for reduction of both mercury and copper. - Environ Health Perspect 102(Suppl 3):305-307 (1994).
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Introduction
The most important mercury-binding pro-
tein in the kidney is metallothionein (MT),
which can bind other divalent essential
metals as well (1). A sequence reflecting
the divalent-binding affinities ofMT is, in
decreasing order, Hg>Cu>Cd>Zn (2). It
has been found that association of mercury
with MT in kidneys resulted in altered
concentration of copper and zinc (3). Since
MT has a high affinity for certain essential
metals, it plays an important role both in
homeostasis of essential metals and in
detoxification ofnonessential metals (4).
Sodium 2,3-dimercaptopropane-1-sul-
fonate (DMPS), presently used as an anti-
dote in mercury intoxication, has a
significant advantage over other chelating
agents. It is water soluble, it has intestinal
absorption of30 to 50%, and it has much
lower toxicity than 2,3-dimercapto-
propanol (BAL) (5). The effectiveness of
DMPS for enhancing mercury elimination
from the kidneys of rats has been reported
both in animals (6) and in man (7).
Mobilization of mercury bound to MT
after chelation with DMPS resulted in
removal ofmercuryfrom MT, and enhance-
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ment ofmercury elimination from the body.
It was proposed that chelators like DMPS,
whose complexes are not lipid soluble,
mainlymobilize mercurystored in thekidney
and favor urinaryexcretion (8).
Although a mercury-copper interaction
was previously found (9), there was no
information available on the effect of
DMPS on copper homeostasis in chronic
mercury intoxication.
The purpose ofthis studywas to deter-
mine the efficiency of DMPS in reducing
mercury deposits in organs after long-term
exposure to inorganic mercury and its effect
on copper levels. We found that DMPS
efficiendy eliminates both copper and mer-
curyfrom kidneystones.
Materials and Methods
Animals
The experiments were performed on 70
female, Wistar-derived rats from the
Institute's breeding farm. Rats were 6weeks
old at the beginning of the experiment
with an average body weight of 127 g.
They were divided into seven groups and
housed in plastic Macrolon cages with five
animals in each cage. Standard commercial
laboratory diet and drinkwere provided ad
libitum Control animals were kept in the
same room with the exposed groups. Food
and drinking water as well as body weights
were recorded weekly. All exposed groups
were given 50 ppm ofmercury (as mercuric
chloride, pa. Kemika, Zagreb, Croatia) in
drinking water. One group was given mer-
cury during 1 month (treatment 1), two
groups were given mercury during two
months (treatment 2) and two groups were
given mercury during one month and dis-
tilled water during another month there-
after (treatment 3). Respective control
groups received distilled water during the
same period. DMPS (Sigma Chemical Co,
St. Louis, MO) was given orallybystomach
tube to mercury-exposed groups in treat-
ments 2 and 3, in a dose of0.44 mmole/kg
body weight during four consecutive days
before the end of the experiment. At the
end of each treatment, animals were sacri-
ficed and kidneys dissected. Left and right
kidneys were used for mercury and copper
analysis, respectively.
Determinaton ofMercuryandCopper
Analysis of mercury was performed using
the cold-vapor atomic absorption spec-
trophotometry method (CVAAS) (JO)
using a Mercury Monitor LDC (Milton
Roy, Riviera Beach, FL). The composite
samples of left kidneys from each group
were used for mercury analysis. Pooled
samples were homogenized and about 1 g of
each sample was wet digested with concen-
trated nitric acid at 800C inclosed ampules.
Mercury analysis was carried out 7 to 18
times in each composite digested sample.
The detection limit ofthe method was
0.4 ng/ml for analyte solution, i.e., 4 ng/g
wet weight of tissue. The accuracy of the
method was checked byanalyzing reference
materials: horse kidney H-8 (IAEA) and
pig kidney CRM-186 (BCR) with reference
values of 910±40 and 1970±40 ng/g
(mean±SEM). Our values obtained for
reference samples were 1010±28 and
1994±40 ng/g, respectively.
Copper was determined by flame
atomic absorption spectrophotometry
(AAS; Varian AA375) with deuterium
background correction. Samples of right
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Table 1. Mercury and copper concentrations in rat kidneys exposed to 50 ppm of mercury (as mercuric chloride) in
drinking water and the effect of DMPS treatment.
Treatmenta
1 2 3
Mercury (pg/gw/w)
Control 0.170 ± 0.007 0.373 ± 0.010
Hg-exposed 122 ± 3.2 124 ± 7.4 75.3 ± 1.7
Hg+DMPSb -58.3 ± 1.3C 27.9 ± 0.7c
Copper (pg/g w/w)
Control 10.7 ± 1.1 14.6 ± 0.8
Hg-exposed 80.0 ± 3.9 77.0 ± 4.6 63.9 ± 3.8
Hg+DMPSb -21.7 ± 1.7c 10.9 ± 0.7c
aTreatments: 1, exposure to mercury during one month; 2, exposure to mercury during two months; 3, exposure to
mercury during one month with an additional recovery period of one month. bDMPS treatment was performed
orally forfour consecutive days at the end of treatments 2 and 3. CSignificantly different from respective mercury-
exposed groups at the level of p<0.001. Each value represents the arithmetic mean ± SE of the mean of 7 tol8
determinations of the composite samples for mercury analysis, and of 10 determinations of individual samples for
copper analysis. Control animals received distilled water.
kidneys were treated individually by wet
digestion with 10 ml ofconcentrated nitric
acid in a digestion system (DS-40, Tecator,
Hoganas, Sweden).
Results are presented as arithmetic
mean±SEM. Differences obtained by
Student's t-test at the 1% confidence level
were denoted as statistically significant.
Results
Body weights of the animals did not differ
significantly in any ofthe treat-ments at the
end of the experiments. The consumption
of drinking water in control and exposed
groups was about 30 and 20 ml, respectively.
The average daily food intake for all groups
was about 15 g. The kidneys ofrats exposed
to mercury during one (treatment 1) or
two (treatment 2) months had mean wet
weights of 1.50±0.03 and 1.66±0.04 g
compared to control groups for the same
period of 1.23±0.03 and 1.31±0.04 g,
respectively. This difference was statistically
significant (p<0.01). Kidney weights after
treatment 3 were 1.42±0.05 g, which was
not significantly different from the control.
Table 1 shows the concentrations of
mercury and copper in the kidneys ofmer-
cury-exposed rats for the various treatment
protocols. These data are compared with
those obtained with DMPS chelation treat-
ments. The results showed that after one or
two months ofexposure to 50 ppm ofmer-
cury, the kidney and mercury concentrations
were 122 and 124 pg/g, respectively. At the
same time, copper rose from 10.7 in control
groups to 80.0 and 77.0 pg/g in exposed
groups, respectively. In treatment 3, after
one month ofrecovery, mercury concentra-
tions lowered spontaneously to 75 pg/g,
while copper levels remained high at 64
j'g/g. Chelation with DMPS (treatment 2)
decreased the concentration of mercury
and copper 2.1- and 3.5-fold, respectively.
Mercury and copper concentrations in rat
kidneys after treatment 3 plus chelation
with DMPS decreased 2.7- and 5.8-fold,
respectively. These results show that only
copper concentrations were returned to
control values after treatment 3 with DMPS.
Discussion
Higher kidney weights but no change in
body weights were observed after one and
two months of exposure to mercury in our
experiments. These data are in agreement
with previously found higher kidney weights
even at a lower mercury concentration in
drinking water, i.e., 20 ppm (1). The kidney
weights of recovered animals (treatment 3)
did not differ significantly from thecontrols.
The concentration ofmercury after one
or two months ofexposure to mercuric chlo-
ride did not differ significantly (p<0.01).
This suggests that the mercury concentration
reaches a steady-state in the rat kidney even
after one month of exposure to inorganic
mercury. Similar mercury kidney levels were
found at different mercury exposure concen-
trations and lengths of mercury exposure
(3,11). In this study, the steady-state mer-
cury concentration obtained in the kidneys
may be due to a balance between enhanced
production and excretion of MT from the
kidneycytosol in urine (2,8,11).
The kidney copper levels in mercury-
intoxicated rats were found to be about six
times higher than in controls and remained
at the same level after one or two months of
mercury exposure. This indicates that copper
also reaches aplateau. The effect ofinorganic
mercury on the accumulation of copper in
rat kidneys has been reported previously
(9,12). Bogden and Boscolo found a 5-fold
higher mean kidney copper concentration
following the exposure to 20 and 50 ppm of
mercury in drinking water during 44 and
350 days, respectively. Marked increases of
copper levels in mercury-intoxicated rats
could be explained by induction of MT
biosynthesis, which can strongly bind copper
alongwith mercury.
Although the mercury-copper interaction
in rat kidneys has previously been reported,
the influence of the chelating agent DMPS
on the level of copper in mercury-exposed
rats had not been studied until now. DMPS
was found to be very efficient in reducing
mercury accumulation in the rat kidneys,
where most of body burden of mercury is
located (6,13). The efficiency of DMPS
treatmentwas found to be dependent on age,
dose, time, and route of administration of
both mercury and chelating agent. Higher
doses of DMPS in delayed treatment were
more effective particulary in reducing mer-
cury accumulation in the kidneys of older
rats (14,15). Mercury and copper concentra-
tions in treatment 2 after chelation with
DMPS were 2.1 and 3.5 times lower than in
respective controls. In treatment 3, after
DMPS chelation, these reduction factors
were even higher, i.e., 2.7 and 5.8, respec-
tively.
We have previously observed that
DMPS, if given orally immediately after
administration of 203 Hg in rats, increases
mercury retention, and we concluded that
DMPS should not be administered orally
while mercury is still in the gastrointestinal
tract (15). In the current experiment DMPS
was administered orally while the animals
were still being treated with mercury in
drinking water. Under these conditions of
exposure, DMPS caused a 2-fold reduction
ofmercury in the kidney. Although we can-
not eliminate the possibility that DMPS
caused increased gastrointestinal absorption
of mercury during the 4 days of treatment,
the 2-fold decrease of kidney mercury indi-
cates that DMPS was able to mobilize the
metal. This mobilization was very effective
even after 1 month ofrecovery from the mer-
cury exposure (Treatment 3) which indicates
that DMPS can be used as late therapy for
elimination ofmercury.
This study demonstrates that chronic
exposure to 50 ppm of mercury induces
changes in the levels ofcopper in rat kidneys,
and that DMPS is an effective antagonist for
reduction ofboth mercury and copper in this
organ. Finally, the protective effect ofDMPS
against mercury-induced toxicity suggests the
need to explore its therapeutic potential as
well as its effect on decreasing copper levels
in diseases unrelated to mercury overload.
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